Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells
- 66 Downloads
The intracellular localization of phosphatidylinositol 3-kinase (PI 3-kinase) has been analyzed by western blotting, confocal, and electron microscopy immunocytochemistry in human osteosarcoma Saos-2 cells. By western blotting, the enzyme appears to be present in both the cytoplasmic and nuclear subfractions. By confocal microscope immunocytochemistry, the cytoplasmic fluorescence is localized in the perinuclear region and on a network of filaments, while a diffused signal is present in the nucleus, except for the nucleolar areas. Ultrastructural analyses on whole cells and on in situ matrix preparations reveal that nuclear PI 3-kinase is localized in interchromatin domains, in stable association with inner nuclear matrix components, while the enzyme diffused in the cytosol is partly associated with the cytoskeletal filaments. Quantitative evaluations indicate that, in a multidrug-resistant variant obtained by continuous exposure of Saos-2 cells to doxorubicin, the amount of nuclear and cytoplasmic PI 3-kinase is significantly lower than in the sensitive parental cell line. The nuclear localization of PI 3-kinase and its variation in multidrug-resistant cells, characterized by a reduced mitotic index, are consistent with the data on the existence of a nuclear inositol lipid cycle, which could also utilize 3-phosphorylated inositides to modulate signal transduction for the control of some key functional activities.
KeywordsNerve Growth Factor Nuclear Matrix Cytoskeletal Filament Matrix Preparation Sensitive Parental Cell Line
Unable to display preview. Download preview PDF.
- Maraldi NM, Zini N, Ognibene A, Martelli AM, Barbieri M, Mazzotti G, Manzoli FA (1995) Immunocytochemical detection of the intranuclear variations of phosphatidylinositol 4,5-bisphosphate amount associated with changes of activity and amount of phospholipase C α1 in cells exposed to mitogenic or differentiating agonists. Biol Cell 83:201–210PubMedCrossRefGoogle Scholar
- Marmiroli S, Ognibene A, Bavelloni A, Cinti C, Cocco L, Maraldi NM (1994) Interleukin-1α stimulated nuclear phosphoinositidase C in human osteosarcoma Saos-2 cells. J Biol Chem 268:13–16Google Scholar
- Morrow CS, Cowan KH (1993) Drug-resistance and cancer. Adv Exp Med Biol 33:287–305Google Scholar
- Yu JC, Heidaran MA, Pierce JH, Gutkind JS, Lombardi D, Ruggiero M, Aaronson SA (1991) Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol 3-kinase activity without affecting mitogenic or chemotactic signal transduction. Mol Cell Biol 11:3780–3785PubMedGoogle Scholar
- Zini N, Neri LM. Ognibene A, Scotlandi K, Baldini N, Maraldi NM (1996) Increase of nuclear phosphatidyinositol 4,5-bis-phosphate and phospholipase C α1 is not associated to variations of protein kinase C in multidrug-resistant Saos-2 cells. Microsc Res Tech (in press)Google Scholar